EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancing brain organoids from disease phenotypes to mechanisms and translation across developmental, infectious, and neurodegenerative diseases

Jürgen A Knoblich, Guo-Li Ming, Sally Temple

Neuron · 2026-11 · 114 (21) · 3984-4008

DOI: 10.1016/j.neuron.2026.10.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuron, 2026-11. Verfasst von Jürgen A Knoblich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria; Medical University of Vienna…. Hauptthemen laut MEDLINE: Organoids, Neurodegenerative Diseases, Brain, Neurodevelopmental Disorders. Die Arbeit nennt 247 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diseases of the central nervous system remain among the greatest unmet medical challenges. Human brain organoids provide 3D multicellular systems for investigating neurodevelopmental, infectious, and neurodegenerative diseases in a human cellular context. Considering these distinct disease areas together highlights how organoid studies are moving beyond recapitulating disease phenotypes to define molecular and cellular mechanisms and trajectories: when pathogenic changes emerge, how they evolve, which cell types and states drive or resist disease, and how multicellular interactions shape progression. Integrating human genetics with longitudinal, single-cell, multi-omic, and functional analyses provides access to human-specific processes that are difficult to capture in animal models and enables identification of mechanisms and therapeutic targets anchored in human disease biology. Increasingly, well-characterized organoids offer human new approach methodologies (NAMs) for preclinical therapeutic evaluation. Advances in reproducibility, benchmarking, and appropriate validation will be critical to establishing their predictive value and supporting their use in drug development and regulatory applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsNeurodegenerative DiseasesBrainNeurodevelopmental DisordersHumansAnimalsPhenotypeNeurodevelopment

Stichwörter der Autor:innen

autismbrain developmentbrain infectionneural organoidsneural stem cellsneurodegenerationneurodevelopmental disorderorganoidsschizophrenia

Autor:innen und Institutionen

  • Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria; Medical University of Vienna, Vienna, Austria.
  • Department of Neuroscience and Mahoney Institute for Neurosciences, Perelman School of Medicine, Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Neural Stem Cell Institute, Regenerative Research Foundation, 150 New Scotland Ave, Albany, NY, USA. Electronic address: sallytemple@neuralsci.org.

Zitieren

APA

Knoblich, J. A., Ming, G. L., & Temple, S. (2026). Advancing brain organoids from disease phenotypes to mechanisms and translation across developmental, infectious, and neurodegenerative diseases. Neuron, 114(21), 3984-4008. https://doi.org/10.1016/j.neuron.2026.10.014

Vancouver

Knoblich JA, Ming GL, Temple S. Advancing brain organoids from disease phenotypes to mechanisms and translation across developmental, infectious, and neurodegenerative diseases. Neuron. 2026;114(21):3984-4008. doi:10.1016/j.neuron.2026.10.014

BibTeX
@article{Knoblich2026,
  author = {Knoblich, Jürgen A and Ming, Guo-Li and Temple, Sally},
  title = {Advancing brain organoids from disease phenotypes to mechanisms and translation across developmental, infectious, and neurodegenerative diseases},
  journal = {Neuron},
  year = {2026},
  volume = {114},
  number = {21},
  pages = {3984--4008},
  doi = {10.1016/j.neuron.2026.10.014}
}
Kostenlos starten →